Business

Vivus Inc.

Advertisement

Vivus, the California maker of the experimental weight loss pill Qnexa, jumped after US regulators ordered changes to a proposed warning label that may mean more women would be able to take the drug. The FDA asked Vivus to remove a contraindication that the drug’s risks outweighed possible benefits for women who could have children, Vivus said. The warning still applies to pregnant women.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.